Doxazosin
- Product NDC
- 71335-9672
- 11-digit product format
- 713359672
- Labeler code
- 71335
- Product ID
- 71335-9672_8b34ead9-50b9-4731-8a62-616b15c55401
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA209013
- Marketing category
- ANDA
- Marketing start
- 2018-04-17
- Marketing end
- 2027-08-31
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197627 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-9672 | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [BRYANT RANCH PREPACK] | 101 | Current NDC, 4 package rows | 20230526_277c3278-4fe2-47ac-9115-15b417325ffd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-9672-1 | 71335967201 | 100 TABLET in 1 BOTTLE (71335-9672-1) | 100 tablet | 2026-04-13 | 2027-08-31 | No | No | Historical |
| 71335-9672-2 | 71335967202 | 30 TABLET in 1 BOTTLE (71335-9672-2) | 30 tablet | 2023-12-21 | 2027-08-31 | No | No | Historical |
| 71335-9672-3 | 71335967203 | 60 TABLET in 1 BOTTLE (71335-9672-3) | 60 tablet | 2026-04-13 | 2027-08-31 | No | No | Historical |
| 71335-9672-4 | 71335967204 | 90 TABLET in 1 BOTTLE (71335-9672-4) | 90 tablet | 2023-03-16 | 2027-08-31 | No | No | Historical |